Stay updated on CDX-0159 in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 is now shown and v3.4.1 was removed. There are no visible changes to study details, criteria, or outcomes.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedThe study status has changed from Active, not recruiting to Completed. Related completion dates were updated and the prior status indicator was removed.SummaryDifference0.2%

- Check32 days agoChange DetectedShow glossary option added and new date/version information (e.g., 2026-01-21, Last Update Posted, Last Update Submitted that Met QC Criteria, Revision: v3.4.0); older entries such as No FEAR Act data and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check39 days agoChange DetectedA new Revision: v3.3.4 label was added and the previous Revision: v3.3.3 label was removed.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded 45 recruitment sites across the United States, Australia, and Canada, expanding geographic coverage for the study.SummaryDifference2%

Stay in the know with updates to CDX-0159 in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page.